Healthcare Plans · Healthcare
Peter Kuipers
Equibles does not estimate personal net worth.
Get an email with a short summary when Clover Health Investments, Corp. publishes a filing, an earnings call transcript or a press release.
Get CLOV alertsAbout Peter Kuipers
Clover Health Investments, Corp. reported in an 8-K filed April 22, 2024 that Peter Kuipers was appointed Interim Senior Vice President of Finance, effective April 29, 2024. The proxy statement of Clover Health Investments, Corp. reports total compensation of $2,045,067 for Peter Kuipers in fiscal 2025, including a base salary of $525,000. Disclosed compensation is on record for 2 fiscal years. Peter Kuipers has spoken on 7 earnings calls and 2 other investor events across 1 company, most recently for Clover Health Investments, Corp. on March 10, 2026. Clover Health Investments, Corp. is classified in the Healthcare Plans industry within the Healthcare sector. Other leadership on record at Clover Health Investments, Corp. includes Andrew Toy (CEO and Board Member), Conrad Wai (CEO and CTO), Jamie L. Reynoso (CEO and COO) and 7 others.
“Prior to his assuming the role of Chief Financial Officer, Mr. Kuipers will initially serve as Interim Senior Vice President of Finance of the Company starting on April 29, 2024.”
Peter Kuipers on recent calls
“Yeah, we'll start with a number of slides and then we'll do Q&A. Let's start with high-level framing. So we at Clover, we are an AI-powered Medicare Advantage plan.”
“Before I walk to the financial results, I want to highlight why we believe Clover is exceptionally well-positioned as we enter 2026 and beyond. We are starting from a position of strength, with improving earnings power, disciplined underwriting, and a technology-enabled model designed to perform across cycles.”
“Before getting into the financials, I want to reiterate Andrew's comments that we remain confident on our long-term trajectory to achieve sustained growth and expanding profitability.”
“We're glad to be here at the Canaccord Growth Conference. We are a tech-enabled insurance company focused on Medicare Advantage that is actually growing amidst tough industry headwinds.”
“Before we get to the financials, I want to emphasize our strong position in today's managed care environment. We are demonstrating great Medicare execution, leading with a wide network PPO plan that currently serves 97% of our members.”
Affiliation history
-
Current
2024-04-29–present
-
Start not stated–2025-04-28
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Clover Health Investments, Corp.
- Andrew Toy CEO, Board Member
- Conrad Wai CEO, CTO
- Jamie L. Reynoso CEO, COO
- Vivek Garipalli Chairman, Board Member
- Clay Thornton CFO
- Joseph Wagner CFO
- Gia Lee General Counsel
- Karen Soares General Counsel
- Joseph (Joe) Oldakowski Chief Accounting Officer
- Mark Herbers Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Clover Health Investments, Corp. (CLOV) | Chief Financial Officer | $525,000 | $2,045,067 |
| 2024 | Clover Health Investments, Corp. (CLOV) | Chief Financial Officer | $367,213 | $4,984,336 |